Botulinum toxin type A for treating voice tremor

Archives of Neurology

Volumn 61, Issue 9, 2004, Pages 1416-1420

  Adler, Charles H ^a   Bansberg, Stephen F ^a   Hentz, Joseph G ^a   Ramig, Lorraine O ^b   Buder, Eugene H ^a,c   Witt, Kristi ^a   Edwards, Brian W ^a   Krein Jones, Kari ^a   Caviness, John N ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MEMPHIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ACOUSTICS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSPHONIA; DYSPNEA; FEMALE; FOLLOW UP; FUNCTIONAL DISABILITY; HUMAN; INDEPENDENT RANDOMIZED TREMOR RATING AND ACOUSTICAL MEASURES; LARYNX DISORDER; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RATING SCALE; RESPONSE RATING SCALE; SCORING SYSTEM; TREMOR; TREMOR RATING SCALE; TREMOR SEVERITY SCALE SCORE; VOCAL CORD;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SOUND SPECTROGRAPHY; TREATMENT OUTCOME; VIDEO RECORDING; VOICE DISORDERS;

EID: 4444363647     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.9.1416     Document Type: Article

References (23)

1. Hubble JP. Essential tremor: diagnosis and treatment. In: Adler CH, Ahlskog JE, eds. Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician. Totowa, NJ: Humana Press; 2000:283-295.
2. Dogu O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology. 2003;61:1804-1806.
3. Massey EW, Paulson GW. Essential vocal tremor: clinical characteristics and response to therapy. South Med J. 1985;78:316-317.
4. Findley LJ, Gresty MA. Head, facial, and voice tremor. In: Jankovic J, Tolosa E, eds. Advances in Neurology: Facial Dyskinesias. Vol 49. New York, NY: Raven Press; 1988:239-253.
5. Koller WC, Glatt S, Biary N, Rubino FA. Essential tremor variants: effect of treatment. Clin Neuropharmacol. 1987;10:342-350.
6. Hubble JP, Busenbark KL, Wilkinson S, et al. Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Mov Disord. 1997;12:337-341.
7. Kumar R, Lozano AM, Sime E, Lang AE. Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. Neurology. 2003;61:1601-1604.
8. Carpenter MA, Pahwa R, Miyawaki KL, Wilkinson SB, Searl JP, Koller WC. Reduction in voice tremor under thalamic stimulation. Neurology. 1998;50:796-798.
9. Brin MF, Blitzer A, Stewart C. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. In: Fahn S, Marsden CD, DeLong M, eds. Dystonia 3: Advances in Neurology. Philadelphia, Pa: Lippincott-Raven; 1998:237-252.
10. Trosch RM, Pullman SL. Botulinum toxin A for the treatment of hand tremors. Mov Disord. 1994;9:601-609.
11. Pahwa R, Busenbark K, Swanson-Hyland EF, et al. Botulinum toxin treatment of essential head tremor. Neurology. 1995;45:822-824.
12. Jankovic J, Schwartz K. Botulinum toxin treatment of tremors. Neurology. 1991;41:1185-1188.
13. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996;11:250-256.
14. Brin MF, Lyons KE, Doucette J, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001;56:1523-1528.
15. Ludlow CL, Sedory SE, Fujita M, Naunton RF. Treatment of voice tremor with botulinum toxin injection. Neurology. 1989;39(suppl 1):353.
16. Brin MF, Blitzer A, Stewart C, et al. Laryngeal botulinum toxin (botox) injections in 431 patients with laryngeal movement disorders: spasmodic dysphonia, adult stuttering and essential voice tremor. Mov Disord. 1992;7(suppl 1):130.
17. Warrick P, Dromey C, Irish JC, Durkin L, Pakiam A, Lang A. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a cross-over design study of unilateral versus bilateral injection. Laryngoscope. 2000;110:1366-1374.
18. Warrick P, Dromey C, Irish J, Durkin L. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice. 2000;14:410-421.
19. Aronson AE, Ramig LO, Winholtz WS, Silber SR. Rapid voice tremor, or "flutter," in amyotrophic lateral sclerosis. Ann Dtol Rhinol Laryngol. 1992;101:511-518.
20. Adler CH. Botulinum toxin treatment of movement disorders. In: Gilman S, Goldstein GW, Waxman SG, eds. Neurobase. 3rd ed. San Diego, Calif: Arbor Publishing; 1999.
21. Buder EH, Strand E. Quantitative and graphic acoustic analysis of phonatory modulations: the modulogram. J Speech Lang Hear Res. 2003;46:475-490.
22. Hertegard S, Granqvist S, Lindestad PA. Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol. 2000;109:204-209.
23. CSpeechSP [computer program], Madison, Wis: University of Wisconsin-Madison; 1997.